High levels of a salivary protein IL-1-beta associated with increased bone loss

NewsGuard 100/100 Score

Researchers at the University at Buffalo have identified two components of saliva that may serve as the basis for novel tests to determine the risk for future loss of the bone that holds teeth in place.

By comparing dental X-rays of 100 patients with analyses of their saliva, the researchers found that higher-than-normal levels of a salivary protein called IL-1-beta were associated with increased bone loss.

The level of another protein, osteonectin, was inversely proportional to bone loss, suggesting this marker may serve as a measure of periodontal health.

Results of the research, a collaboration between the UB School of Dental Medicine and the UB School of Public Health and Health Professions, were presented at the annual meeting of the International Association of Dental Research held in Orlando, Fla.

"These results show that above-average levels of IL-1 beta in saliva may prove to help the dentist decide whether or not to treat the dental patient for periodontal disease," said lead researcher Frank Scannapieco, D.D.S., Ph.D., professor and chair of the Department of Oral Biology in the UB dental school.

"Currently there is no early warning test for bone-loss activity," Scannapieco added. "We can measure gum pocket depth, or the amount of bone remaining on an X-ray, but these methods only tell us how much damage already has been done. If these findings hold up in future longitudinal studies, the dental practitioner might use a test to decide what interventions are needed for the patient, and perhaps the frequency for recall visits.

"This biomarker test also could provide a quick and easy way to monitor patients over the long-term and to determine if a particular treatment is working," he said.

Periodontal bone loss is a serious oral-health condition that can cause teeth to loosen and fall out. The availability of a simple test would reduce the need to submit every patient to expensive, time-consuming and often uncomfortable X-rays and pocket-probing exams, which measure how much of the tooth-supporting bone already has been lost due to periodontal (gum) disease. Such a test also may help a dentist decide how often a patient needs tooth cleaning.

Previous studies had identified specific protein biomarkers of bone destruction in fluid collected from gum crevices in patients with active periodontal disease, but collecting enough of this fluid for analysis can be tedious and time consuming, whereas saliva is plentiful and easily collected.

The research team now is performing follow-up studies to determine the validity of their results.

http://www.buffalo.edu

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Blood protein could be a potential biomarker for delayed concussion recovery in children